Verified Nov 2026
Other
·
Exeter, New Hampshire
·
Since 1999
Vapotherm is a medical technology company headquartered in Exeter, New Hampshire, United States, founded in 1999. It employs roughly 200 to 500 people, with an estimated revenue band of $50 to $100 million. The company is privately held following a 2024 transaction. It develops and sells non-invasive respiratory care devices used with hospitals and healthcare facilities. In 2026 it received FDA 510(k) clearance for its All Patient Circuit, which supports high velocity therapy for neonatal through adult patients.
Vapotherm at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
1999
Headquarters
Exeter, New Hampshire
Import activity
170
Industries
Automotive
Electric Vehicles
Electronics
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
170
Named foreign suppliers
22
Top origins
China · Italy · Hong Kong S.A.R. · South Korea
Shared foreign counterparties do not establish that these companies buy from Vapotherm.
What this tells a buyer
Vapotherm announced FDA 510(k) clearance for its All Patient Circuit on 20 April 2026, and on 1 October 2026 it expanded its High Velocity Therapy offering with that circuit available as a standard option.
The company's core capability is High Velocity Nasal Insufflation, delivered through its Precision Flow systems and disposable accessories, and it is positioned for respiratory care in hospital settings.
Vapotherm operates in the medical industry and has a reported public sector maintenance tender for its devices, indicating ongoing installed-base service relationships.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Vapotherm is a medical technology company headquartered in Exeter, New Hampshire, United States, founded in 1999. It employs roughly 200 to 500 people, with an estimated revenue band of $50 to $100 million. The company is privately held following a 2024 transaction. It develops and sells non-invasive respiratory care devices used with hospitals and healthcare facilities. In 2026 it received FDA 510(k) clearance for its All Patient Circuit, which supports high velocity therapy for neonatal through adult patients.
At a glance
Attribute | Detail |
|---|---|
Founded | 1999 |
Headquarters | Exeter, New Hampshire |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What Vapotherm makes
The company's core capability is High Velocity Nasal Insufflation, delivered through its Precision Flow systems and disposable accessories, and it is positioned for respiratory care in hospital settings.
Trade and customs footprint
Vapotherm announced FDA 510(k) clearance for its All Patient Circuit on 20 April 2026, and on 1 October 2026 it expanded its High Velocity Therapy offering with that circuit available as a standard option. US customs bill-of-lading records list 170 inbound shipments across 22 foreign suppliers, with top origins including China · Italy · Hong Kong S.A.R. · South Korea.
Latest developments
2026-10-01 — Vapotherm® Expands High Velocity Therapy® with All Patient Circuit™ Available as Standard DPC and Aerosol Circuit - Vapotherm (vapotherm.com)
2026-09-24 — Vapotherm stock shifts to private ownership after 2024 deal (ad-hoc-news.de)
2026-06-01 — C443781 - Waiver for Maintenance of Vapotherm Devices | Public sector tender | Stotles (stotles.com)
2026-04-20 — Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients - Vapotherm (vapotherm.com)
2026-02-04 — Vapotherm 12 month activation for precision flow system - Find a Tender (service.gov.uk)
2025-12-08 — Vapotherm and Flight Medical Announce Partnership to Bring the VentO2ux™ Ventilator to US Hospitals - Vapotherm (vapotherm.com)
Company details
Vapotherm operates in the medical industry and has a reported public sector maintenance tender for its devices, indicating ongoing installed-base service relationships. Vapotherm was founded in 1999, has an estimated 200-500 employees, and is headquartered in Exeter, New Hampshire.
Frequently asked questions
What does Vapotherm do?
Vapotherm is a medical technology company headquartered in Exeter, New Hampshire, United States, founded in 1999. It employs roughly 200 to 500 people, with an estimated revenue band of $50 to $100 million. The company is privately held following a 2024 transaction. It develops and sells non-invasive respiratory care devices used with hospitals and healthcare facilities. In 2026 it received FDA 510(k) clearance for its All Patient Circuit, which supports high velocity therapy for neonatal through adult patients.
Where is Vapotherm headquartered?
Vapotherm is headquartered in Exeter, New Hampshire (100 Domain Drive, Exeter, New Hampshire, 03833).
When was Vapotherm founded?
Vapotherm was founded in 1999.
How big is Vapotherm?
Vapotherm has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Does Vapotherm import from overseas suppliers?
US customs bill-of-lading records show 170 inbound shipments for Vapotherm, with top origins including China · Italy · Hong Kong S.A.R. · South Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.